Advertisement

Reactions Weekly

, Volume 1694, Issue 1, pp 1–1 | Cite as

Agranulocytosis risk with clozapine still needs monitoring

News item
  • 37 Downloads

Reference

  1. Health Canada. Summary Safety Review - Clozapine - Assessing the effectiveness of monitoring for low numbers of white blood cells. Internet Document : 9 Mar 2018. Available from: URL: https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/safety-reviews/clozapine-white-blood-cells.html

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations